Gene · 407041
Papers2,389
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,389
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MiR-146a rs2910164 (G/C) polymorphism is associated with the development and prognosis of acute coronary syndromes: an observational study including case control and validation cohort. | J Transl Med | 2023 | 37189131 | PubTator, text mining | PubMed |
| Endothelial cells secrete small extracellular vesicles bidirectionally containing distinct cargo to uniquely reprogram vascular cells in the circulation and vessel wall. | bioRxiv | 2023 | 37162986 | PubTator, text mining | PubMed |
| Targeted therapy using nanocomposite delivery systems in cancer treatment: highlighting miR34a regulation for clinical applications. | Cancer Cell Int | 2023 | 37149609 | PubTator, text mining | PubMed |
| Circular RNAs: pivotal role in the leukemogenesis and novel indicators for the diagnosis and prognosis of acute myeloid leukemia. | Front Oncol | 2023 | 37124518 | PubTator, text mining | PubMed |
| The MIR34B/C genomic region contains multiple potential regulators of multiciliogenesis. | FEBS Lett | 2023 | 37102425 | PubTator, text mining | PubMed |
| Identification of Common Dysregulated Genes in COVID-19 and Hypersensitivity Pneumonitis: A Systems Biology and Machine Learning Approach. | OMICS | 2023 | 37062762 | PubTator, text mining | PubMed |
| Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis. | Respir Res | 2023 | 37061683 | PubTator, text mining | PubMed |
| Clinical Application of Small Extracellular Vesicles in Gynecologic Malignancy Treatments. | Cancers (Basel) | 2023 | 37046644 | PubTator, text mining | PubMed |
| The Pleiotropic Face of CREB Family Transcription Factors. | Mol Cells | 2023 | 37013623 | PubTator, text mining | PubMed |
| Nanotechnology in Cancer Diagnosis and Treatment. | Pharmaceutics | 2023 | 36986885 | PubTator, text mining | PubMed |
| MiRNAs in Hematopoiesis and Acute Lymphoblastic Leukemia. | Int J Mol Sci | 2023 | 36982511 | PubTator, text mining | PubMed |
| Extracellular Vesicles, Cell-Penetrating Peptides and miRNAs as Future Novel Therapeutic Interventions for Parkinson's and Alzheimer's Disease. | Biomedicines | 2023 | 36979707 | PubTator, text mining | PubMed |
| Circulating Biomarkers for Cancer Detection: Could Salivary microRNAs Be an Opportunity for Ovarian Cancer Diagnostics? | Biomedicines | 2023 | 36979630 | PubTator, text mining | PubMed |
| MAPK Is a Mutual Pathway Targeted by Anxiety-Related miRNAs, and E2F5 Is a Putative Target for Anxiolytic miRNAs. | Biomolecules | 2023 | 36979479 | PubTator, text mining | PubMed |
| IDH2 Deficiency Promotes Endothelial Senescence by Eliciting miR-34b/c-Mediated Suppression of Mitophagy and Increased ROS Production. | Antioxidants (Basel) | 2023 | 36978833 | PubTator, text mining | PubMed |
| Crosstalk Between miRNA and Protein Expression Profiles in Nitrate-Exposed Brain Cells. | Mol Neurobiol | 2023 | 36971918 | PubTator, text mining | PubMed |
| MicroRNAs in septic acute kidney injury. | Burns Trauma | 2023 | 36959845 | PubTator, text mining | PubMed |
| Anti-tumor effects of miR-34a by regulating immune cells in the tumor microenvironment. | Cancer Med | 2023 | 36951490 | PubTator, text mining | PubMed |
| Profiling of Circulating Tumor Cells for Screening of Selective Inhibitors of Tumor-Initiating Stem-Like Cells. | Adv Sci (Weinh) | 2023 | 36949364 | PubTator, text mining | PubMed |
| Decreased circulating microRNA-21 and microRNA-143 are associated to pulmonary hypertension. | Turk J Med Sci | 2023 | 36945942 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407041/papers?page=9